赛马鲁肽
医学
肥胖
内科学
内分泌学
2型糖尿病
利拉鲁肽
糖尿病
作者
Daniel Weghuber,Timothy Barrett,Margarita Barrientos-Pérez,Inge Gies,Dan Hesse,Ole K. Jeppesen,Aaron S. Kelly,Lucy D. Mastrandrea,Rasmus Sørrig,Silva Arslanian
标识
DOI:10.1056/nejmoa2208601
摘要
A once-weekly, 2.4-mg dose of subcutaneous semaglutide, a glucagon-like peptide-1 receptor agonist, is used to treat obesity in adults, but assessment of the drug in adolescents has been lacking.
科研通智能强力驱动
Strongly Powered by AbleSci AI